Latest News Feed

Royal Biologics Launches Amnio-Maxx™, an Extracellular Matrix Product Derived From Human Amniotic Placental Tissue
FEATURED
Press Release Feb 6, 2018
Royal Biologics Launches Amnio-Maxx™, an Extracellular Matrix Product Derived From Human Amniotic Placental Tissue

50% Commission Offering for Initial Distributors. Amnio-Maxx™ will be used to treat various conditions in orthopedics and sports medicine.
Royal Biologics Launches Maxx-Cell, the World's Most Advanced Bone Marrow Aspiration Device
Press Release Jun 18, 2018
Royal Biologics Launches Maxx-Cell, the World's Most Advanced Bone Marrow Aspiration Device

Maxx-Cell has created a new gold standard in bone marrow aspiration therapy.
Royal Biologics Launches MAXX™-Fuse
Press Release Feb 20, 2018
Royal Biologics Launches MAXX™-Fuse

Royal Biologics Launches MAXX™-Fuse, a demineralized bone matrix product derived from 100 percent human bone